Klingenstein Fields & Co’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$221K Sell
827
-450
-35% -$122K 0.01% 177
2025
Q4
$320K Hold
1,277
0.01% 146
2025
Q3
$367K Hold
1,277
0.01% 141
2025
Q2
$335K Hold
1,277
0.01% 140
2025
Q1
$297K Sell
1,277
-569
-31% -$138K 0.01% 148
2024
Q4
$423K Sell
1,846
-84
-4% -$19.3K 0.02% 124
2024
Q3
$431K Sell
1,930
-1,127
-37% -$248K 0.02% 129
2024
Q2
$622K Hold
3,057
0.03% 109
2024
Q1
$668K Sell
3,057
-142
-4% -$31.3K 0.03% 110
2023
Q4
$727K Sell
3,199
-75
-2% -$15.8K 0.03% 106
2023
Q3
$658K Sell
3,274
-537
-14% -$113K 0.03% 106
2023
Q2
$790K Sell
3,811
-23
-0.6% -$4.46K 0.04% 101
2023
Q1
$756K Hold
3,834
0.04% 101
2022
Q4
$776K Hold
3,834
0.04% 103
2022
Q3
$675K Buy
3,834
+342
+10% +$70K 0.04% 104
2022
Q2
$703K Sell
3,492
-888
-20% -$189K 0.04% 108
2022
Q1
$992K Sell
4,380
-2,550
-37% -$600K 0.04% 103
2021
Q4
$1.87M Sell
6,930
-6,298
-48% -$1.56M 0.08% 88
2021
Q3
$3.2M Sell
13,228
-171,864
-93% -$43.3M 0.14% 78
2021
Q2
$43.9M Sell
185,092
-226
-0.1% -$51.5K 1.81% 15
2021
Q1
$40.6M Sell
185,318
-4,106
-2% -$824K 1.84% 15
2020
Q4
$33.1M Sell
189,424
-1,988
-1% -$343K 1.5% 19
2020
Q3
$31M Sell
191,412
-610
-0.3% -$96.7K 1.55% 20
2020
Q2
$27.4M Buy
192,022
+1,402
+0.7% +$194K 1.5% 21
2020
Q1
$20.7M Sell
190,620
-5,729
-3% -$825K 1.35% 21
2019
Q4
$28.5M Sell
196,349
-2,820
-1% -$407K 1.44% 25
2019
Q3
$28.7M Buy
199,169
+11,529
+6% +$1.68M 1.52% 20
2019
Q2
$27.9M Buy
187,640
+2,353
+1% +$328K 1.45% 22
2019
Q1
$24.4M Sell
185,287
-60,112
-24% -$7.41M 1.31% 27
2018
Q4
$26.6M Sell
245,399
-2,083
-0.8% -$279K 1.13% 27
2018
Q3
$36.9M Sell
247,482
-2,436
-1% -$371K 1.32% 19
2018
Q2
$38.5M Buy
249,918
+1,199
+0.5% +$181K 1.47% 17
2018
Q1
$34.6M Buy
248,719
+484
+0.2% +$71.1K 1.32% 20
2017
Q4
$34M Sell
248,235
-400
-0.2% -$52.9K 1.25% 21
2017
Q3
$32.2M Sell
248,635
-7,304
-3% -$974K 1.24% 22
2017
Q2
$33.9M Buy
255,939
+10,375
+4% +$1.27M 1.33% 20
2017
Q1
$30.3M Buy
245,564
+1,074
+0.4% +$127K 1.23% 23
2016
Q4
$27M Buy
244,490
+2,911
+1% +$323K 1.18% 24
2016
Q3
$28.5M Sell
241,579
-71
-0% -$8.37K 1.31% 21
2016
Q2
$27M Buy
241,650
+13,800
+6% +$1.49M 1.26% 21
2016
Q1
$22.9M Buy
227,850
+1,878
+0.8% +$180K 1.15% 26
2015
Q4
$24M Sell
225,972
-5,134
-2% -$530K 1.19% 25
2015
Q3
$21.5M Sell
231,106
-2,800
-1% -$290K 1.07% 28
2015
Q2
$24.4M Sell
233,906
-1,368
-0.6% -$142K 1.09% 30
2015
Q1
$25.5M Sell
235,274
-13,560
-5% -$1.39M 1.13% 27
2014
Q4
$23.1M Buy
248,834
+225,752
+978% +$19.9M 1.03% 31
2014
Q3
$2.02M Sell
23,082
-1,746
-7% -$158K 0.09% 103
2014
Q2
$2.18M Sell
24,828
-4,150
-14% -$359K 0.09% 107
2014
Q1
$2.44M Sell
28,978
-114,548
-80% -$9.13M 0.11% 99
2013
Q4
$11.3M Sell
143,526
-2,799
-2% -$239K 0.4% 64
2013
Q3
$12.5M Sell
146,325
-76,255
-34% -$6.42M 0.49% 58
2013
Q2
$19.1M Buy
+222,580
New +$18.5M 0.69% 41

Other funds holding LH

Klingenstein Fields & Co's LH Position: Q1 2026 in Review

Klingenstein Fields & Co reduced its Labcorp (LH) stake by 35% in Q1 2026, selling an estimated $122K and leaving 827 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #177.

Klingenstein Fields & Co first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.9M in Q2 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Klingenstein Fields & Co held 827 shares of Labcorp worth $221K as of Q1 2026.
  • Klingenstein Fields & Co sold 450 Labcorp shares in Q1 2026, an estimated $122K.
  • Labcorp made up 0.01% of Klingenstein Fields & Co's portfolio in Q1 2026, its #177 holding.
  • Klingenstein Fields & Co first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Klingenstein Fields & Co's Labcorp position peaked at $43.9M in Q2 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.